Ifosfamide / mesna Alternatives Compared
Ifosfamide / mesna | Cisplatin | Etoposide |
|
---|
Ifosfamide / mesna | Cisplatin | Etoposide |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Testicular Cancer. Ifosfamide / mesna may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Bladder Cancer, Anal Cancer, Bone Marrow Transplantation, Blood Cell Transplantation, Brain Tumor, Cervical Cancer, Nasopharyngeal Carcinoma, Neuroblastoma, Non Small Cell Lung Cancer... View more |
Prescription only
Prescribed for Ovarian Cancer, Small Cell Lung Cancer, Hodgkin's Lymphoma, Cancer, Multiple Myeloma, Testicular Cancer. Etoposide may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Cisplatin | More about Etoposide | |||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Cisplatin has an average rating of 8.0 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
Etoposide has an average rating of 7.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Ifosfamide / mesna side effects |
View all Cisplatin side effects |
View all Etoposide side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cisplatin prices |
View all Etoposide prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
Etopophos, Toposar | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
15 hours |
73 hours |
11 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 594 drugs are known to interact with Ifosfamide / mesna:
|
A total of 468 drugs are known to interact with Cisplatin:
|
A total of 473 drugs are known to interact with Etoposide:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
December 19, 1978 |
December 30, 1986 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.